Test 165

Marcus opened the sub-50-seat thing in our 1:1. Friendly, no weird edge, just basically: Tomas wants to know if Q3 is real and what it'd take from my side. I told him 10 days for a scoping doc, so May 26. My read is this is not just packaging/pricing. It's entitlement logic, onboarding path, support volume, probably sales-assist rules, and a bunch of annoying exceptions if we let SMB accounts buy their way into stuff built for 200-seat teams. I'd scope around seat caps first, then feature fences, then where the handoffs break -- billing, workspace limits, permissions, import/migration, who gets human help. If they want a clean yes/no by end of month, fine, but the doc has to name what we'd refuse.

I've incorporated Priya's requested revision into my final midyear self-review. The outcome section separates my judgment from the implementation owned by Owen, Daniela, Ines, and Customer Success; the growth-edge section owns my delayed leadership call and names a concrete H2 commitment. The review is due Friday. Email Priya the final draft below today with the subject `Midyear self-review — Riley Tanaka`. Outcomes and judgment I defined the evidence and decision boundaries for Helio Start from signup through the first paid month. I kept admission routing, pre-admission assistance, post-admission support, activation, and first-paid evidence distinct; pushed for the connector-access check when credential failures were obscuring setup fit; and framed the May decision around what the evidence could support. That helped Helio continue the bounded organic path through Q3 without turning early activation evidence into a paid-acquisition or pipeline claim. Team contribution The operating result was shared work. Owen owned the reporting implementation and denominator checks, Daniela built and validated the instrumentation, Ines carried the lifecycle QA, and Customer Success operated the assisted routes. My contribution was setting the questions, making the evidence limits explicit, and ensuring that the continuation decision did not claim more than the team had measured. Growth edge and H2 commitment I waited too long to name which ambiguities needed an explicit owner, especially timestamp semantics, finance dependencies, and validation responsibility. That was a leadership delay, not just a tooling issue. In H2, I will assign ownership for metric definitions, finance inputs, and validation at the start of evidence work, with unresolved semantics recorded before implementation begins.

Marcus opened the sub-50-seat thing in our 1:1. Friendly, no weird edge, just basically: Tomas wants to know if Q3 is real and what it'd take from my side. I told him 10 days for a scoping doc, so May 26. My read is this is not just packaging/pricing. It's entitlement logic, onboarding path, support volume, probably sales-assist rules, and a bunch of annoying exceptions if we let SMB accounts buy their way into stuff built for 200-seat teams. I'd scope around seat caps first, then feature fences, then where the handoffs break -- billing, workspace limits, permissions, import/migration, who gets human help. If they want a clean yes/no by end of month, fine, but the doc has to name what we'd refuse.